Quebec City (Quebec), May 14, 2013 - Atrium Innovations inc. (TSX: ATB) ("Atrium" or the "Company") announced today that all of the nominees listed in the Management Proxy Circular dated March 28, 2013 were elected as directors of Atrium by a majority of the votes cast by the shareholders present or represented by proxy. The detailed results of the vote for the election of the directors at Atrium's Annual General Meeting of Shareholders held earlier today in Montreal are set out below.

For Withold
Number % Number %
Yvon Bolduc 18 888 515 97,76 431 946 2,24
Alain Bouchard 17 686 414 91,54 1 634 048 8,46
Éric Dupont 19 209 248 99,42 111 214 0,58
Pierre Fitzgibbon 18 765 377 97,13 555 085 2,87
Jacques Gauthier 18 818 278 97,40 502 184 2,60
Claude Lamoureux 18 799 402 97,30 521 061 2,70
Pierre Laurin 18 382 170 95,14 938 292 4,86
Gérard Limoges 18 880 842 97,72 439 620 2,28
Javier San Juan 19 230 587 99,53 89 876 0,47
Carole St-Charles 18 710 139 96,84 610 324 3,16

About Atrium Innovations

Atrium Innovations Inc. (TSX: ATB) is a globally recognized leader in the development, manufacturing, and commercialization of innovative, science-based natural health products which are distributed in more than 35 countries. The Company owns healthcare practitioner and specialized retail product brands that are at the forefront of science, innovation and education. Atrium has over 1,100 employees and operates seven manufacturing facilities complying with current Good Manufacturing Practices. Additional information is available at www.atrium-innovations.com.

Investor Relations:

Mario Paradis
Vice President and Chief Financial Officer
Tel. : (418) 652-1116
mp@atrium-innovations.com

Pierre Boucher
MaisonBrison Communications
Tel. : (514) 731-0000, ext 237
pierre@maisonbrison.com

Media Relations:

Amélie Germain
Director of Communications
Tel. : (418) 652-1116
ag@atrium-innovations.com

- 30 -

distributed by